Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$181,681,275
+$22,322,845 QoQ
Shares Held
151,473
-12.6% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#277
of 4,605 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Sep 30, 2025CallValue
$20,829,900
CallShares
27,300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Temasek Holdings (Private) Ltd holds $391,677,477 across 3 Drug Manufacturers - General names. LLY ranks #1 (46.4% of the industry book) .
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $181,681,275 | 151,473 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $159,358,430 | 173,259 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $126,647,825 | 117,847 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $20,829,900 | 27,300 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $108,091,158 | 141,666 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $85,172,227 | 109,261 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $79,031,327 | 95,690 | Shares | Defined | 2025-05-16 | |
| 2024-12-31 | $54,271,600 | 70,300 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $62,281,582 | 70,300 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $27,417,622 | 30,283 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||